Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 367

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action

Buttgereit, Frank, Straub, Rainer H., Wehling, Martin, Burmester, Gerd‐Rüdiger·2004·Arthritis & Rheumatism

Abstract

Six years after we published our first article on the mechanisms of action of glucocorticoids (GCs) (1), there is already a need for an update. GCs are superior to many drugs in terms of the number of patients treated, the variety of potential uses, and the experience with treatment in humans. They still represent the most important and most frequently used class of antiinflammatory drugs, and their therapeutic use has risen continuously in recent years (2). About 10 million new prescriptions for oral GCs are written each year in the US alone (2). They are the silent companions of rheumatologists, and it is impossible to imagine therapy— especially oral therapy, but intravenous and intraarticular as well—without them. From community survey data, the frequency of oral GC use has been estimated to be 0.5% of the general population and 1.75% of women over the age of 55 years (3,4). Between 56% and 68% of patients with rheumatoid arthritis are treated more or less continuously with GCs (5–8). GCs are relatively inexpensive drugs, but it is the sheer volume used that is significant overall; the total market size is believed to be about 10 billion US dollars per year (2). Our understanding of the actions of GCs has also greatly increased in the last few years. In this review, we report on recent insights relating to 1) signaling, transcription processes, and gene expression as induced, inhibited, and/or modified by the interaction of GCs with their cytosolic receptors, 2) relationships between dosages and plasma levels, 3) membrane-bound GC receptors (GCRs), and 4) new (glucocorticoid) drugs on the horizon. These data support the modular concept we proposed in 1998 (1), and so this update follows the same structure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.20583

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 367

Metadata

Authors
Buttgereit, F., Straub, R. H., Wehling, M., & Burmester, G.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2004-11
Volume
50
Issue
11
Pages
3408-3417
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2063467177
Cited by
367
References
60
FWCI
9.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action. https://app.cochat.ai/papers/10.1002/art.20583
The paper
Buttgereit, F., Straub, R. H., Wehling, M., & Burmester, G. (2004). Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action. Arthritis & Rheumatism. https://doi.org/10.1002/art.20583

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.